Cargando…
Halting coronavirus polymerase
The nucleotide analogue remdesivir is an investigational drug for the treatment of human coronavirus infection. Remdesivir is a phosphoramidate prodrug and is known to target viral RNA-dependent RNA polymerases. In this issue, Gordon et al. identify that remdesivir acts as a delayed RNA chain termin...
Autor principal: | Kirchdoerfer, Robert N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152748/ https://www.ncbi.nlm.nih.gov/pubmed/32277065 http://dx.doi.org/10.1074/jbc.H120.013397 |
Ejemplares similares
-
The antiviral compound remdesivir potently inhibits RNA-dependent RNA
polymerase from Middle East respiratory syndrome coronavirus
por: Gordon, Calvin J., et al.
Publicado: (2020) -
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
por: Gordon, Calvin J., et al.
Publicado: (2020) -
An unstructured proteasome inhibitor comes into focus
por: Nemec, Antonia A., et al.
Publicado: (2023) -
Plasmodium falciparum finds the winning combination
por: Hengge, Alvan C.
Publicado: (2021) -
Iron chelates hitch a ride on PAT1
por: Collins, James F.
Publicado: (2021)